Drug recall D-0893-2023
Product
ZIPRASIDONE HYDROCHLORIDE CAPSULES 20 mg, Unit Dose Carton 40 Capsules, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited Bachupally-500 090 India, Distributed by: Major Pharmaceuticals Livonia, MI 48152 USA, NDC 0904-6269-08
Reason for recall
Labeling: Label Mix-up: Unit Dose cartons labeled as Ziprasidone Hydrochloride Capsules, 20 mg were found to contain blister packages labeled as and containing Dronabinol Capsules, USP, 2.5 mg.
Lots and codes
Lot: T04769 Exp. 2024/12
Recall details
- Recalling firm
- The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories, La Vergne, TN
- Quantity
- unknown
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 31, 2023
- Terminated
- July 2, 2024
Related products
- Ziprasidone – drug information
- NDC 0904-6271 Ziprasidone · Ziprasidone Hydrochloride 60 mg/1 · Major Pharmaceuticals
- NDC 0904-6270 Ziprasidone · Ziprasidone Hydrochloride 40 mg/1 · Major Pharmaceuticals
- NDC 0904-6269 Ziprasidone · Ziprasidone Hydrochloride 20 mg/1 · Major Pharmaceuticals
- NDC 0904-6272 Ziprasidone · Ziprasidone Hydrochloride 80 mg/1 · Major Pharmaceuticals